Van Strum & Towne’s Edwards Lifesciences EW Stock Holding History

Van Strum & Towne’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$567K	Sell	7,081 -53	-0.7%	-$4.37K	0.17%	68
2025 Q4	$608K	Hold	7,134	–	–	0.17%	72
2025 Q3	$555K	Hold	7,134	–	–	0.16%	72
2025 Q2	$558K	Hold	7,134	–	–	0.18%	69
2025 Q1	$517K	Hold	7,134	–	–	0.17%	71
2024 Q4	$528K	Buy	7,134 +326	+5%	+$22.8K	0.19%	64
2024 Q3	$449K	Hold	6,808	–	–	0.16%	71
2024 Q2	$629K	Hold	6,808	–	–	0.23%	59
2024 Q1	$651K	Hold	6,808	–	–	0.24%	59
2023 Q4	$519K	Hold	6,808	–	–	0.2%	59
2023 Q3	$472K	Hold	6,808	–	–	0.2%	58
2023 Q2	$642K	Hold	6,808	–	–	0.27%	55
2023 Q1	$563K	Hold	6,808	–	–	0.24%	57
2022 Q4	$508K	Hold	6,808	–	–	0.22%	56
2022 Q3	$563K	Hold	6,808	–	–	0.26%	57
2022 Q2	$647K	Hold	6,808	–	–	0.28%	51
2022 Q1	$801K	Hold	6,808	–	–	0.3%	53
2021 Q4	$882K	Hold	6,808	–	–	0.32%	52
2021 Q3	$771K	Hold	6,808	–	–	0.3%	51
2021 Q2	$705K	Hold	6,808	–	–	0.34%	46
2021 Q1	$569K	Hold	6,808	–	–	0.29%	49
2020 Q4	$621K	Buy	+6,808	New	+$565K	0.35%	42

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Van Strum & Towne's EW Position: Q1 2026 in Review

Van Strum & Towne reduced its Edwards Lifesciences (EW) stake by 0.74% in Q1 2026, selling an estimated $4.37K and leaving 7,081 shares worth $567K. The position accounts for 0.17% of the portfolio, ranked #68.

Van Strum & Towne first reported a position in EW in Q4 2020 and has held it in 22 quarters since. The position peaked at $882K in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Van Strum & Towne held 7,081 shares of Edwards Lifesciences worth $567K as of Q1 2026.
Van Strum & Towne sold 53 Edwards Lifesciences shares in Q1 2026, an estimated $4.37K.
Edwards Lifesciences made up 0.17% of Van Strum & Towne's portfolio in Q1 2026, its #68 holding.
Van Strum & Towne first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 22 quarters since.
Van Strum & Towne's Edwards Lifesciences position peaked at $882K in Q4 2021.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Van Strum & Towne's 13F filing for Q1 2026, filed 7 May 2026.